{"podcast":{"title":"Business News Today | 2 Min News | The Daily News Now!","slug":"business-finance-news-today-2-min-news-the-daily-news-now-7726192","podcast_index_feed_id":7726192,"rss_url":"https://feeds.fastcast.ai/the-daily-news-now-business.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/cover/a77b5c94-431e-4490-8653-1f676f1da586.png","author":"The Daily News Now!","episode_count":2000,"summary":"Hosted by Corey with the Story, Business News Today is your daily source for the latest headlines and stories shaping the world of business, finance, and the global economy. From market trends and corporate earnings to startups, entrepreneurship, technology, real estate, consumer trends, and economic policy, we bring you the business news that matters most—in just a few minutes. Whether you're an entrepreneur, investor, executive, business owner, or simply someone who wants to stay informed, Business News Today delivers clear, concise updates to help you understand the forces shaping the economy and the future of business. Business News Today — Business news, all in one place. Powered by AI.","last_synced_at":"2026-09-17T06:21:31.382927+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192"},"episode":{"title":"Is AdaptHealth a Buy or Risk","slug":"is-adapthealth-a-buy-or-risk","published_at":"2026-06-11T12:00:40+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/is-adapthealth-a-buy-or-risk","show_page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192","url":"https://api.fastcast.ai/audio/529be97f-f088-45f9-8d69-94f44f8822cb.mp3","audio_url":"https://api.fastcast.ai/audio/529be97f-f088-45f9-8d69-94f44f8822cb.mp3","summary":"AdaptHealth’s stock has stalled near $9.94, lagging behind the S&P 500, as flatlining revenue growth, declining profitability, and dismal capital efficiency raise serious concerns. Despite rising revenue, earnings per share have dropped 12.4% annually over five years, and returns on invested capital hover at just 0.3%—worse than the cost of capital. While not a total write-off, the fundamentals suggest significant risk, prompting analysts to steer investors toward stronger alternatives like dominant software firms. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/25c7b61438a62caa","meta_description":"AdaptHealth’s stock has stalled near $9.94, lagging behind the S&P 500, as flatlining revenue growth, declining profitability, and dismal capital effi…","key_points":[],"chapters":[],"topics":[],"duration_seconds":111,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/is-adapthealth-a-buy-or-risk/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/is-adapthealth-a-buy-or-risk.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}